Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. (ENUM) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 10 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jan 3, 2017 involved a transaction of 66,666 shares valued at $0.
ENUM Insider Activity Summary
Who Is Buying ENUM Stock?
No significant insider buying has been recorded for ENUM in the recent period.
Who Is Selling ENUM Stock?
No significant insider selling has been recorded for ENUM in the recent period.
Is Enumeral Biomedical Holdings, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ENUM is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
ENUM Frequently Asked Questions
Understanding ENUM Insider Activity
Insider trading at Enumeral Biomedical Holdings, Inc. (ENUM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading ENUM stock, having executed 10 transactions in the past 90 days. The most active insider is Robert J. Easton (Executive), who has made 1 transactions totaling $62.4K.
Related Tools
Track Enumeral Biomedical Holdings, Inc. Insider Activity
Get notified when executives and directors at ENUM file new Form 4 transactions